Is Orkambi deal close? Vertex meets again today with NHS England

21 March 2019 - Campaigners hopes rise after three year wait. ...

Read more →

Ontario may lift ban preventing major pharmacies from selling private-label generic drugs

21 March 2019 - Ontario Premier Doug Ford’s government is considering lifting a ban that prevents major pharmacy chains from ...

Read more →

PBAC Report - Options for listing PD-(L)1 checkpoint inhibitors for multiple cancer indications on the PBS

22 March 2019 - The PBAC Report to the Minister for Health on “Options for listing PD(L)-1 checkpoint inhibitors for multiple ...

Read more →

Enzyvant's investigational Farber disease enzyme replacement therapy, RVT-801, receives FDA fast track and rare paediatric disease designations

21 March 2019 - Enzyvant today announced that the U.S. FDA has granted are paediatric disease and fast track designations for ...

Read more →

NICE terminates yet another assessment of a cancer medicine

20 March 2019 - This time it is pembrolizumab (Keytruda). ...

Read more →

Promoting biosimilars up to health plans, manufacturers, doctors, Gottlieb says

21 March 2019 - As he wraps up his final weeks as commissioner of the FDA, Scott Gottlieb, MD, talked about ...

Read more →

Kentucky launches probe into drug overcharges by pharmacy benefit managers

22 March 2019 - Kentucky Attorney General Andy Beshear said on Thursday he had launched an investigation into allegations that ...

Read more →

Institute for Clinical and Economic Review releases draft evidence report on esketamine for treatment-resistant depression

21 March 2019 - Public comment period now open until 17 April 2019; requests to make oral comment during public meeting ...

Read more →

Mystery solved: the pharma-backed group with a lot to say on Trump’s pitch to end drug rebates

20 March 2019 - RetireSafe, a Washington-based advocacy group with ties to the drug industry, appears to be behind a ...

Read more →

FDA approves new device for treating moderate to severe chronic heart failure in patients

21 March 2019 - The U.S. FDA today approved the Optimizer Smart system for treating patients with chronic, moderate-to-severe heart failure ...

Read more →

Why Ontario parents could soon be paying more for prescription drugs

22 March 2019 - Some Ontario parents will be paying more for their kids’ medicine starting next month. Young adults ...

Read more →

Struggling to stay alive: rising insulin prices cause diabetics to go to extremes

20 March 2019 - The escalating cost of insulin has desperate diabetics rationing medication, acquiring the drug from friends or getting ...

Read more →

AbbVie is sued for using Humira patent deals to block competition in the U.S.

20 March 2019 - In a novel step, a New York union accused AbbVie and seven other drug makers of ...

Read more →

Jazz Pharmaceuticals announces U.S. FDA approval of Sunosi (solriamfetol) for excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea

20 March 2019 - Sunosi is the first and only dual-acting dopamine and norepinephrine re-uptake inhibitor approved by the FDA to ...

Read more →

York man Paul Thomas-Peter says he could die because NHS won't fund drug

19 March 2019 - A York cancer patient says he could die because the NHS refuses to fund immunotherapy treatment ...

Read more →